Disappointment as tenofovir gel study bombs

2011-12-02 00:00

PROFESSOR Salim Abdool Karim, director of the Centre for the Aids Programme of Research in South Africa (Caprisa) expressed his disappointment at recent findings showing that tenofovir gel does not effectively reduce HIV infections in women.

Caprisa carried the study.

This follows the announcement this week that tenofovir gel, a clinical trial vaginal preparation designed to reduce HIV infections, has been found to be ineffective and is to be suspended.

Karim was speaking to journalists during the World Aids Day commemorations at Mafakatini area in Vulindlela yesterday, where the community came in their numbers.

Among those in attendance were local inkosi Sondelani Zondi, inkosi Nsikayezwe Zondi and Science and Technology Deputy Minister Derek Hanekom.

Karim thanked the women from the area who volunteered for the study, even thoughthe gel was found to be ineffective in a recent study conducted by the National Institutes of Health in the United States

The U.S. version of the Caprisa study is known as the vaginal and oral interventions to control the epidemic (Voice).

“We do not know how the Voice was conducted, but we cannot dismiss their findings,” Karim said, adding that Caprisa still has to conduct its own research.

He said the Caprisa study showed that 39% of women who used the gel within two hours before sex and two hours after displayed reduced HIV infections, while the gel actually killed off infections in 59% of women who used it regularly.

“However the Voice study revealed that women had to use it every day, not only when they are having sex, and we have no way of knowing how honest they were when asked if they have used the gel,” said Karim.

He said the researchers were disappointed with the Voice results because they were hoping that it would corroborate those of the Caprisa.

“We did not want a situation of learning of our failure after the gel was distributed throughout the country. But this has also delayed our plans to have the gel distributed by 2013,” said Karim.

He said Caprisa will conduct a study to determine where the study had erred, and that it will take about four to six months to phase out its study of women in the Vulundlela area.

Hanekom said, “We as the government are committed to supporting the work done by Caprisa because we cannot give in just because of the recent findings. It is our responsibility as the government to fight this pandemic until a solution has been found, but we are convinced that we are winning our war against HIV and Aids.”

• thobani.ngqulunga@witness.co.za

Join the conversation!

24.com encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions.

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
0 comments
Comments have been closed for this article.

Inside News24

 
/News

Book flights

Compare, Book, Fly

Traffic Alerts
There are new stories on the homepage. Click here to see them.
 
English
Afrikaans
isiZulu

Hello 

Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.


Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.

Settings

Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.




Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.